# TRIPLEX (NCT05223647)

> Chemo-immunotherapy Plus Thoracic Radiotherapy in Extensive Stage Small-cell Lung Cancer

No report yet. It can be ordered.

## Registry

- Registry record: https://clinicaltrials.gov/study/NCT05223647
- Phase: PHASE3
- Status: TERMINATED
- Sponsor: Norwegian University of Science and Technology
- Conditions: Small-cell Lung Cancer
- Interventions: Thoracic radiotherapy; Chemo-immunotherapy
- Enrollment: 239
- Primary outcome: Change in 1-year overall survival

## Preliminary discovery

Commentary in our index that names this trial so far. Final coverage is set when the report is built.

- X threads: 2
- Bluesky threads: 1

## Order

Focused, $750, price fixed at order: https://www.erudio.com/contact?report=triplex-nct05223647